Antitumor steroids: 1. Synthesis and biological activity of 11α-hydroxyestra-1,3,5(10)-triene derivatives with bis-(2-chloroethyl) amino-containing substituent at position 3

Pharmaceutical Chemistry Journal

Volumn 41, Issue 4, 2007, Pages 183-187

  Rzheznikov, V M ^a   Golubovskaya, L E ^a   Minailova, O N ^a   Keda, B I ^a   Ivanenko, T I ^a   Fedotov, V P ^a   Sushinina, L P ^b   Titova, T A ^b   Tolkachev, V N ^b   Osetrova, I P ^c   Smirnova, Z S ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; MELANOMA; MOUSE; NONHUMAN; SARCOMA;

EID: 35448960441     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-007-0042-1     Document Type: Article

References (23)

1. Cytotoxic estrogens in hormone receptive tumors, J. Raus, H. Martens, and G. Leclercq (eds.), London, New York, Toronto, Sydney, San Francisco (1980).
2. C. E. Arris, C. Bleasdale, A. H. Calvert, et al., Anti-Cancer Drug Des., 9, 401-408 (1994).
3. O. O. Clement, C. M. Freeman, R. W. Hartman, et al., J. Med. Chem., 46, 2345-2351 (2003).
4. M. D. Mashkovskii, Drugs [in Russian], Meditsina, Moscow (1993), Vol. 2, p. 556.
5. N. J. Bundred, Cancer Treat. Rev., 27(3), 137 (2001).
6. Z. Smirnova, I. Osetrova, V. Rzheznikov, et al., XVI-th Int. Cancer Congress, New Delhi (1996), p. 301.
7. L. Ferland, F. Labric, P. A. Kelly, and J. P. Raynaud, Biol. Reprod., 18, 99-104 (1978).
8. V. M. Rzheznikov, Khim. Prir. Soedin., No. 5, 729-730 (1991).
9. Z. P. Sofina and N. D. Lagova, Sov. Med. Rev. Oncol., 4, 1-55 (1992).
10. D. Y. Collins and Y. Sjovall, Austr. J. Chem., 36, 339-360 (1983).
11. R. C. Cambie and N. F. Carlisle, J. Chem. Sos., 8, 1706 (1970).
12. P. J. Sykes, F. G. Rutherford, S. B. Laing, et al., Tetrahedron Lett., 3393-3396 (1971).
13. V. M. Rzheznikov, Zh. Org. Khim., 25, 1568-1570 (1989).
14. L. E. Golubovskaya, O. N. Minailova, V. M. Rzheznikov, and V. N. Tolkachev, Abstr. II-th Int. Sympos. on the Chemistry of Natural Comp., Eskisehir, Turkey (1996), p. 138.
15. Y. Wu and L. F. Blackwell, Steroids, 58, 452-456 (1993).
16. K. Kuhajda, J. Kandrac, V. Cirin-Novta, and D. Milkovic, Collect. Czech. Chem. Commun., 61, 1073-1076 (1996).
17. L. E. Golubovskaya and V. M. Rzheznikov, Zh. Org. Khim., 41(2), 305 (2005).
18. D. M. Brown, in: Advances in Organic Chemistry: Methods and Results, R. Raphael, E. Taylor, et al. (eds.), New York (1963).
19. L. E. Golubovskaya, Z. S. Smirnova, V. N. Tolkachev, and V. M. Rzheznikov, Bioorg. Khim., 32(2), 118 (2006).
20. L. E. Golubovskaya and V. M. Rzheznikov, Zh. Org. Khim., 34(12), 1772 (1998).
21. Methodological Guide on the Experimental (Preclinical) Investigation of New Pharmaceuticals [in Russian], Remedium, Moscow (2000), pp. 319-325.
22. H. Michina, M. R. Schneider, El. Nishino, and M. F. Etreby, J. Steroid Biochem., 34, 447-453 (1989).
23. J. Bowler, T. J. Lilley, J. D. Pittam, A. E. Wakeling, Steroids, 54, 71-100 (1989).